Petersen, Antonia
Nagel, Sebastian Niko
Hamm, Bernd
Elgeti, Thomas
Schaafs, Lars-Arne
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 23 August 2023
Accepted: 28 February 2024
First Online: 5 March 2024
Competing interests
: The authors report no competing interests. Bernd Hamm reports grants not related to the current study from Abbott, Actelion Pharmaceuticals, Bayer Schering Pharma, Bayer Vital, BRACCO Group, Bristol-Myers Squibb, Charité Research Organisation GmbH, Deutsche Krebshilfe, Dt. Stiftung für Herzforschung, Essex Pharma, European Society of Radiology, Fibrex Medical Inc., Focused Ultrasound Surgery Foundation, Fraunhofer Gesellschaft, Guerbet, INC Research, InSightec Ltd., IPSEN Pharma, Kendle/MorphoSys AG, Lilly GmbH, Lundbeck GmbH, MeVis Medical Solutions AG, Nexus Oncology, Novartis, Parexel CRO Service, Perceptive, Pfizer GmbH, Philipps, sanofi-aventis S.A., Siemens, Spectranetics GmbH, Terumo Medical Corporation, TNS Healtcare GmbH, Toshiba, UCB Pharma, Wyneth Pharma, Zukunftsfonds Berlin (TSB).